The manufacturer of a blood thinner will pay $650 million to settle claims brought by 4,000 consumers and next of kin who claimed to have been injured by the drug. Boehringer Ingelheim Pharmaceuticals, makers of Pradaxa, agreed on the settlement this week, resolving litigation that began in Novembe ... More >>
Families suing the maker of anti-clotting drug Pradaxa will have their cases consolidated in an East St. Louis, Illinois, court -- a decision the Texas-based law firm leading the suits is calling a coup. Pradaxa hit the U.S. market in 2010, hailed by manufacturer Boehringer Ingelheim as a major le ... More >>
There's only one really bad thing about the anti-clotting pill Pradaxa. You can't fall or get cut while taking it because once you start bleeding, there's almost no way to stop it. There's no reversal agent, no antidote.
Approved by the Food and Drug Administration in 2010, a blood-thinner called Pradaxa was a great leap forward in the treatment of a heart disorder called atrial fibrillation. Or at least that's how it was marketed. There was just one slight problem: Unlike the drug it was meant to replace, Pradaxa ... More >>